Welcome to PsychU!

Virtual Event – Considerations & Factors For Initiating & Switching Antipsychotic Medications In Schizophrenia

Loading Events

Virtual Event – Considerations & Factors For Initiating & Switching Antipsychotic Medications In Schizophrenia

A Virtual Event for PsychU members in Arkansas, Kansas, Missouri, & Oklahoma.

This presentation will examine the essential factors for consideration when initiating and/or switching antipsychotic treatments in schizophrenia. Both general and specific factors unique to patient and medication are implemented into selecting the most appropriate switch strategy. Potential withdrawal and rebound effects during switch will be thoroughly discussed.

Featuring

  • Roger Sommi, PharmD, FCCP, BCPP

    Associate Dean, UMKC School of Pharmacy – University of Missouri

  • Julleah Johnson, PhD (OPDC)

    Senior Medical Science Liaison

Roger Sommi, PharmD, FCCP, BCPP is a paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Julleah Johnson, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.